ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

5.66

-0.17 (-2.90%)

Jul 30, 2026, 10:23 AM EDT - Market open

ARS Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	562	1,157	1,033	528	801	202
Market Cap Growth	-68.81%	11.93%	95.59%	-34.07%	296.19%	-87.42%
Enterprise Value	549.16	1,009	719.44	300.27	527.44	227.27
Last Close Price	5.66	11.65	10.55	5.48	8.53	6.66

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	131.88	-	-	-
PS Ratio	5.85	13.73	11.59	17611.80	608.92	36.73
PB Ratio	9.44	10.12	4.02	2.29	2.94	-6.47
P/TBV Ratio	11.88	11.51	4.33	2.26	1.25	-
P/FCF Ratio	-	-	79.59	-	-	-
P/OCF Ratio	-	-	76.28	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.55	11.97	8.07	10008.90	400.79	41.28
EV/FCF Ratio	-	-	55.41	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.57	0.84	0	0.00	0.00	0.20
Debt / FCF Ratio	-	-	0.00	-	-	-
Net Debt / Equity Ratio	-1.69	-1.30	-1.22	-0.99	-1.00	1.63
Net Debt / EBITDA Ratio	0.52	0.83	104.52	3.38	7.72	2.65
Net Debt / FCF Ratio	0.59	0.87	-24.18	3.84	6.80	2.90
Asset Turnover	0.32	0.25	0.31	0.00	0.01	0.02
Inventory Turnover	2.98	3.01	0.37	-	-	-
Quick Ratio	4.63	6.91	13.75	95.51	50.40	7.34
Current Ratio	4.94	7.28	14.26	96.92	51.01	7.42
Return on Equity (ROE)	-225.53%	-92.33%	3.28%	-21.59%	-21.84%	-9.47%
Return on Assets (ROA)	-65.80%	-52.85%	-1.02%	-26.24%	-20.72%	-8.53%
Return on Invested Capital (ROIC)	-	-	-	-8134.94%	-	-
Return on Capital Employed (ROCE)	-76.90%	-58.24%	-1.10%	-26.65%	-21.57%	-8.87%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-	-	0.76%	-	-	-
FCF Yield	-	-	1.26%	-	-	-
Buyback Yield / Dilution	-1.59%	3.74%	-7.54%	-138.30%	-38.39%	-893.01%
Total Shareholder Return	-1.59%	3.74%	-7.54%	-138.30%	-38.39%	-893.01%

SEC Filings: 10-K · 10-Q